Company / Current Liabilities per Share
Rapport Therapeutics, Inc. Current Liabilities per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.42
FY2024
5-year range
$0.42 / $5.85
FY2023-FY2024
Trend
-92.8%
vs FY2023
Sector context
#160 of 210
Health Care
What the data says
Rapport Therapeutics, Inc.'s current liabilities per share of $0.42 is lower than 76% of companies in the Health Care sector (FY2024).
Based on SEC 10-K filings.
0.42 in FY2024.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 210This company $0.42 Sector average $23.79
▼
-98.2% below sector average
Key checks
Key Insights
- In FY2024, current liabilities per share decreased 92.8% year-over-year.
- Ranks #160 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 13.36 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.42 | -92.8% |
| FY2023 | $5.85 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026